(Q37535345)

20 August 2017

1 reference

title

Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction (English)

1 reference

20 August 2017

1 reference

1 reference

neuromuscular junction

1 reference

Jaap J Plomp

1

1 reference

PubMed ID

19564393

20 August 2017

Hugh J Willison

series ordinal

2

1 reference

PubMed ID

19564393

20 August 2017

language of work or name

English

0 references

publication date

29 June 2009

1 reference

20 August 2017

Journal of Physiology

1 reference

20 August 2017

587

1 reference

20 August 2017

Pt 16

1 reference

20 August 2017

3979-3999

1 reference

Gangliosides in the nervous system

20 August 2017

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Synaptic function of cholinergic-specific Chol-1alpha ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Gangliosides and sialylcholesterol as modulators of synaptic functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

The Guillain-Barré syndrome: a true case of molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Perisynaptic Schwann cells at the neuromuscular junction: nerve- and activity-dependent contributions to synaptic efficacy, plasticity, and reinnervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Structure, function, and regulation of the skeletal muscle dihydropyridine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Anti-ganglioside antibodies alter presynaptic release and calcium influx

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

SNARE proteins are highly enriched in lipid rafts in PC12 cells: implications for the spatial control of exocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Glycosphingolipids with extended sugar chain have specialized functions in development and behavior of Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

IVIg in other autoimmune neurological disorders: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

The calcium channel alpha2delta-2 subunit partitions with CaV2.1 into lipid rafts in cerebellum: implications for localization and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

The developmental expression of the cholinergic-specific antigen Chol-1 in the central and peripheral nervous system of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Glycolipid and ganglioside metabolism imbalances in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Effects of the mono- and tetrasialogangliosides GM1 and GQ1b on ATP-induced long-term potentiation in hippocampal CA1 neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Gangliosides GM1 and GM3 in the living cell membrane form clusters susceptible to cholesterol depletion and chilling

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Effect of the mono- and tetra-sialogangliosides, GM1 and GQ1b, on long-term potentiation in the CA1 hippocampal neurons of the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Surface charges and ion channel function

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

GD3 synthase gene knockout mice exhibit thermal hyperalgesia and mechanical allodynia but decreased response to formalin-induced prolonged noxious stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Ultrastructural localization of cell membrane G M1 ganglioside by cholera toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Lipid rafts and membrane traffic

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Advances in the understanding of the mechanism of action of IVIg

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

21 January 2018

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Anti-ganglioside complex antibodies in Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Gangliosides affect membrane-channel activities dependent on ambient temperature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Involvement of gangliosides in glycosylphosphatidylinositol-anchored neuronal cell adhesion molecule TAG-1 signaling in lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

The relation of clinical symptoms and anti-ganglioside antibodies to MEPPs frequency increase in 8 cases of variant type Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

IgG from patients with Guillain-Barré syndrome interact with nicotinic acetylcholine receptor channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Hyperreflexia in axonal Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Biology of gangliosides: neuritogenic and neuronotrophic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Ganglioside function in calcium homeostasis and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

GM1 ganglioside: another nuclear lipid that modulates nuclear calcium. GM1 potentiates the nuclear sodium-calcium exchanger

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Clinical and immunological spectrum of the Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Immunotherapy for anti-GQ1b IgG antibody-mediated disorders: role of electrophysiology in human trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Acute ophthalmoparesis in the anti-GQ1b antibody syndrome: electrophysiological evidence of neuromuscular transmission defect in the orbicularis oculi

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Glycosylation of glycolipids in the Golgi complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal

21 January 2018

2 references

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2756433

Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina

5 November 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Gangliosides and glycosphingolipids of peripheral nervous system myelins--a minireview

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Immunoseparation of sphingolipid-enriched membrane domains enriched in Src family protein tyrosine kinases and in the neuronal adhesion molecule TAG-1 by anti-GD3 ganglioside monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Differential involvement of gangliosides versus phospholipids in the process of temperature adaptation in vertebrates. A comparative phenomenological and physicochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Calcium-ganglioside interactions and synaptic plasticity: effect of calcium on specific ganglioside/peptide (valinomycin, gramicidin A)-complexes in mixed mono- and bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

The complement system in the peripheral nerve: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Gangliosides improve synaptic transmission in dentate gyrus of hippocampal rat slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Occurrence of sialic acids in Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Neurophysiology of the neuromuscular junction: overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Lipid rafts and the regulation of exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Ganglioside GD1a increases the excitability of voltage-dependent sodium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Lambert-eaton myasthenic syndrome: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

The alpha-galactosyl derivatives of ganglioside GD(1b) are essential for the organization of lipid rafts in RBL-2H3 mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Functional rafts in cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Structural factors influencing the efficacy of neuromuscular transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Gangliosides as components of lipid membrane domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

alpha-Latrotoxin and its receptors: neurexins and CIRL/latrophilins

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

The synaptic vesicle cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Sensory nerve-dominant nerve degeneration and remodeling in the mutant mice lacking complex gangliosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Gangliosides enhance KCl-induced Ca2+ influx and acetylcholine release in brain synaptosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Role of lipid microdomains in P/Q-type calcium channel (Cav2.1) clustering and function in presynaptic membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Gangliosides and synaptic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Alpha-latrotoxin: from structure to some functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Segregation of gangliosides GM1 and GD3 on cell membranes, isolated membrane rafts, and defined supported lipid monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

The role of monosialoganglioside GM1 in the synaptic plasticity: in vitro study on rat hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

The immunopathogenesis of Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Anti-ganglioside antibodies and the presynaptic motor nerve terminal

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Peripheral neuropathies and anti-glycolipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Safety factor at the neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Induction of calcium influx through TRPC5 channels by cross-linking of GM1 ganglioside associated with alpha5beta1 integrin initiates neurite outgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Gangliosides stimulate calcium flux in neuro-2A cells and require exogenous calcium for neuritogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Sphingolipids as receptor modulators. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Bacterial infections in Guillain-Barré and Fisher syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Neuromuscular synaptic function in mice lacking major subsets of gangliosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Regulation of ganglioside biosynthesis in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Designation and schematic structure of gangliosides and allied glycosphingolipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Intravenous immunoglobulin therapy for Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

A case of recurrent Miller Fisher syndrome mimicking botulism

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FJPHYSIOL.2009.171702

Neuromuscular synaptic transmission in aged ganglioside-deficient mice.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2756433

Regulation of ganglioside biosynthesis in the nervous system

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2756433

The interchangeability of the complement components of different animal species; literature survey.

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2756433

Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function.

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2756433

Miller Fisher syndrome: immunofluorescence and immunoelectron microscopic localization of IgG at the mouse neuromuscular junction

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2756433

Complement. First of two parts

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2756433

Cerebellar neurons lacking complex gangliosides degenerate in the presence of depolarizing levels of potassium

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2756433

Gangliosides as modulators of neuronal calcium.

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2756433

Endogenous ganglioside GM1 modulates L-type calcium channel activity in N18 neuroblastoma cells

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2756433

Studies on the Functions of Gangliosides in the Central Nervous System

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2756433

Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block

5 November 2018

1 reference

12 December 2020

Biosynthesis and functions of gangliosides: recent advances

1 reference

12 December 2020

Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome

1 reference

12 December 2020

Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies

1 reference

12 December 2020

Impaired neuromuscular junction transmission in anti-GQ1b antibody negative Miller Fisher variant

1 reference

12 December 2020

Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study

1 reference

12 December 2020

Structure and dynamics of sialic acid at the surface of a magnetically oriented membrane system

1 reference

12 December 2020

Anti-GM2 gangliosides IgM paraprotein induces neuromuscular block without neuromuscular damage

1 reference

12 December 2020

Dysfunction at the motor end-plate and axon membrane in Guillain-Barré syndrome: a single-fiber EMG study

1 reference

12 December 2020

Cav2.1 voltage-dependent Ca2+ channel current is inhibited by serum from select patients with Guillain-Barré syndrome

1 reference

12 December 2020

GM3 ganglioside induces hamster fibrobiast growth inhibition in chemically-defined medium: Ganglioside may regulate growth factor receptor function

1 reference

12 December 2020

Refractory skin injury in complex knock-out mice expressing only the GM3 ganglioside

1 reference

12 December 2020

Effect of gangliosides on adenylate cyclase activity in rat cerebral cortical membranes

1 reference

12 December 2020

Anti-ganglioside complex antibodies associated with severe disability in GBS

1 reference

12 December 2020

Failure of 3,4-diaminopyridine to reverse conduction block in inflammatory demyelinating neuropathies

1 reference

12 December 2020

Neuromuscular junction dysfunction in Miller Fisher syndrome

1 reference

12 December 2020

Presynaptic neuromuscular transmission defect in the Miller Fisher syndrome

1 reference

12 December 2020

Single-fiber electromyography shows terminal axon dysfunction in Miller Fisher syndrome: a case report

1 reference

12 December 2020

Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates

1 reference

12 December 2020

IgG anti-GalNAc-GD1a antibody inhibits the voltage-dependent calcium channel currents in PC12 pheochromocytoma cells

1 reference

12 December 2020

Presynaptic neuromuscular transmission block in Guillain-Barré syndrome associated with anti-GQ1b antibodies

1 reference

12 December 2020

Motor nerve sprouting induced by ganglioside treatment. Possible implications for gangliosides on neuronal growth

1 reference

12 December 2020

Acetylcholine sensitivity of developing ectopic nerve-muscle junctions in adult rat soleus muscles

1 reference

12 December 2020

b-series Ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve

1 reference

12 December 2020

Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release

1 reference

12 December 2020

Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease

1 reference

12 December 2020

Electrophysiological differences in seropositive and seronegative Lambert-Eaton myasthenic syndrome

1 reference

12 December 2020

Anti-GD2-like IgM autoreactivity in multiple sclerosis patients

1 reference

12 December 2020

Activation of (Na+, K+)-ATPase by nanomolar concentrations of GM1 ganglioside

1 reference

12 December 2020

Facile methods for isolation and determination of gangliosides in a small scale: age-related changes of gangliosides in mouse brain synaptic plasma membranes

1 reference

12 December 2020

Electrophysiological evidence by single fibre electromyography of neuromuscular transmission impairment in a case of Miller Fisher syndrome

1 reference

12 December 2020

L-type calcium channels are involved in fast endocytosis at the mouse neuromuscular junction

1 reference

12 December 2020

Recurrent miller fisher syndrome with abnormal terminal axon dysfunction: a case report

1 reference

12 December 2020

Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity

1 reference

12 December 2020

Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals

1 reference

12 December 2020

Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody

1 reference

12 December 2020

Changes in the neuromuscular synapse induced by an antibody against gangliosides

1 reference

12 December 2020

The influence of exogenous gangliosides on the dynamics of the development of prolonged posttetanic potentiation

1 reference

12 December 2020

Anti-GQ1b antibodies and evoked acetylcholine release at mouse motor endplates

1 reference

12 December 2020

Guillain-Barré syndrome

1 reference

12 December 2020

10.1113/JPHYSIOL.2009.171702

Identifiers

DOI

1 reference

20 August 2017

0 references

1 reference

PubMed ID

19564393